Navigation Links
Temple University Health System to Benefit from Verizon Wireless Network Enhancements
Date:8/11/2009

ing an array of inpatient and outpatient services to its surrounding community and highly specialized tertiary services to the entire Philadelphia region and beyond. Temple is well known for its expertise in cardiology, pulmonary, sports medicine and gastroenterology and is the chief clinical training site for the Temple University School of Medicine. Temple was a founding member of the Health System in 1994.


'/>"/>
SOURCE Verizon Wireless
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
2. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
3. Temple University Hospital, Temple University School of Medicine and Crozer-Keystone Health System Collaborate to Provide Comprehensive Kidney Care
4. 4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists
5. Temple and Fox Chase partner on research and education
6. Thomson Reuters Honors Temple University Health System for Initiative That Cut Costs $64 Million and Grew Clinical Service Lines
7. Temple University Hospital Ranked Among Best in America for Respiratory Disorders by U.S. News & World Report
8. Temple, Fox Chase and Geisinger create Keystone Institute for Translational Medicine
9. PAs Smoking Ban Should Filter Into Homes and Cars Too, According to Temple University Expert
10. Temple researchers look for behavioral link between breastfeeding and lower risk of obesity
11. Local Physicians of Indian Origin To Offer Free Health Screenings at The Hindu Temple of Canton
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3ASTRO Gildas Club Chicago join to promote cancer survivorship 59515 1Biomedical Research Centre searches for immunological biomarkers 59513 1Biomedical Research Centre searches for immunological biomarkers 59513 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 1KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 10371 4